Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02343003 · ClinicalTrials.gov registry record · NA
Nerve Ablation by Cooled Radiofrequency Compared to Corticosteroid Injection for Management of Knee Pain
A NA study of Osteoarthritis of the Knee, sponsored by Halyard Health.
- Completed
- Registry status
- NA
- Development phase
- 151
- Enrollment target
- 11
- Study locations
NCT02343003: Completed NA study of Osteoarthritis of the Knee, sponsored by Halyard Health.
NCT02343003 is a NA study of Osteoarthritis of the Knee that has completed, run by Halyard Health. The registered enrollment target is 151 participants, below the 203-participant average among 16 other Osteoarthritis of the Knee trials with a reported enrollment target (26% lower). The trial reports 11 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02343003, a NA study of Osteoarthritis of the Knee, has completed, sponsored by Halyard Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 151 participants
- Enrollment target
- 11
- Study locations
Study Summary
This study is designed to: * Determine the effectiveness (primarily measured by pain relief) of Coolief when used to create radiofrequency lesions of the genicular nerves compared to pain relief following corticosteroid injection; and * Confirm the safety of Coolief when used to perform radiofrequency lesions of the genicular nerves in subjects to manage knee pain compared to safety of corticosteroid injection
Primary Outcome
The number of subjects whose knee pain is reduced by ≥ 50% based on the Numeric Rating Scale (NRS). The NRS is an 11-point scale (0 points to 10 points), where 0 points equals "no pain" and 10 points equals the "worst pain".
Conditions Studied
Interventions
- DRUG Corticosteroid injection
- DEVICE Cooled Radiofrequency
Study Locations (11)
Arizona
- Valley Anesthesiology Consultants - Estrella - Phoenix
- Valley Anesthesiology Consultants/Valley Pain Consultants - Scottsdale
California
- Orthopedic Pain Specialists - Santa Monica
Illinois
- Rush University Medical Center - Chicago
Minnesota
- MAPS Applied Research Center, Inc. - Maple Grove
New York
- Ainsworth Institute of Pain Management - New York
North Carolina
- Center for Clinical Research - Winston-Salem
Pennsylvania
- Drexel University - Philadelphia
South Carolina
- Piedmont Comprehensive Pain Management - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2015-01 |
| Est. Completion | 2017-03-16 |
| Phase | NA |
What the finished NCT02343003 record still lists
NCT02343003 is an interventional study that assigns participants to a tested intervention. The registered 151 participants enrollment target is mid-sized for trials with a published cap, below the 203-participant average among 16 other Osteoarthritis of the Knee trials with a reported enrollment target (26% lower).
The record links to 1 condition, with Osteoarthritis of the Knee appearing as the primary indexed condition, and to 2 interventions - of which Corticosteroid injection is the first listed.
NCT02343003 lists 11 locations in 10 states (Arizona, California, Illinois).
Frequently Asked Questions
What is clinical trial NCT02343003 about?
NCT02343003 is a clinical study titled "Nerve Ablation by Cooled Radiofrequency Compared to Corticosteroid Injection for Management of Knee Pain". This study is designed to: * Determine the effectiveness (primarily measured by pain relief) of Coolief when used to create radiofrequency lesions of the genicular nerves compared to pain relief following corticosteroid injection; and * Confirm the safety of Coolief when used to perform radiofreque...
What is the current status of trial NCT02343003?
This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2015-01. Estimated completion is 2017-03-16.
What conditions does trial NCT02343003 study?
This clinical trial studies the following conditions: Osteoarthritis of the Knee.
What interventions are being tested in trial NCT02343003?
The interventions under investigation include: Corticosteroid injection (DRUG), Cooled Radiofrequency (DEVICE).
Who is sponsoring clinical trial NCT02343003?
This trial is sponsored by Halyard Health, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02343003 being conducted?
This trial has 11 study locations across Arizona, California, Illinois, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis of the Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02343003's enrollment target sits among peer trials
151 11th of 16 higher than 6 of 16 other Osteoarthritis of the Knee trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis of the Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection
RECRUITING · NA
-
Home-Based Leg Dexterity Trainer for Management of Knee Osteoarthritis
RECRUITING · NA
-
Sleep, Pain and Inflammatory Processes in Older Adults With Osteoarthritis
COMPLETED · NA
-
Cooled Radiofrequency vs. Hyaluronic Acid to Manage Knee Pain
COMPLETED · NA
-
Coolief Cooled Radiofrequency vs. Conventional Radiofrequency to Manage OA Knee Pain
COMPLETED · NA
-
Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01409161 · 151 participants · Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- NCT04245397 · 151 participants · Phase 1
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- NCT05761223 · 151 participants · Phase 1
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
- NCT07195656 · 151 participants · NA
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia